MolecularMD
Specialty biomarker laboratory services supporting biomarker development across exploratory, translational and clinical stages. Services include assay design, verification and validation, genomics and molecular pathology workflows (IHC, mIF, flow cytometry), trial-integrated biomarker strategy, regulatory support and program-level scientific advice to enable biomarker-informed clinical decision-making.
Industries
Nr. of Employees
medium (51-250)
MolecularMD
Portland, Oregon, United States, North America
Services
End-to-end assay design, verification and validation for exploratory, translational and clinical use, including support for regulatory submissions and companion diagnostics.
Genomics-based biomarker analyses for retrospective and prospective studies to support target identification, PD markers and patient selection.
Custom IHC assay development and validation for biomarker detection in tissue samples.
Slide-based multiplex immunofluorescence assay development and implementation to generate multiplexed biomarker data.
Customised flow cytometry assay development and execution for cellular biomarker analysis.
Collaborative design services to embed biomarkers into clinical protocols, define endpoints and validation plans, and provide scientific oversight.
End-to-end assay design, verification and validation for exploratory, translational and clinical use, including support for regulatory submissions and companion diagnostics.
Genomics-based biomarker analyses for retrospective and prospective studies to support target identification, PD markers and patient selection.
Custom IHC assay development and validation for biomarker detection in tissue samples.
Slide-based multiplex immunofluorescence assay development and implementation to generate multiplexed biomarker data.
Customised flow cytometry assay development and execution for cellular biomarker analysis.
Collaborative design services to embed biomarkers into clinical protocols, define endpoints and validation plans, and provide scientific oversight.
Expertise Areas
- Biomarker development and validation
- Clinical biomarker integration and trial design
- Genomics and molecular analysis
- Molecular pathology and IHC
Key Technologies
- Genomics
- Immunohistochemistry (IHC)
- Multiplex immunofluorescence (mIF)
- Flow cytometry
News & Updates
Expert-led report exploring how biomarker science advances trial design and clinical decision-making.
Discussion of clinical trial protocol design considerations in the context of changing IVD regulations.
Article on the increasing role of biomarkers in early clinical development.
Expert-led report exploring how biomarker science advances trial design and clinical decision-making.
Discussion of clinical trial protocol design considerations in the context of changing IVD regulations.
Article on the increasing role of biomarkers in early clinical development.